Articles tagged with Viral Infections
Researchers discovered that laminins, specifically laminin γ1, play a crucial role in mediating cell attachment and penetration for oncolytic viruses like H-1PV. This finding may lead to the development of more efficient clinical trials with reduced costs and approval times.
Researchers from the Institute of Physical Chemistry found that phage potency is affected by container material, leading to reduced efficacy. The study highlights the importance of using specific containers with controlled surface properties to maintain phage concentration.
Researchers identified unique antibody responses that correlate with protection against dengue fever, highlighting the need for vaccines targeting specific serotypes. The study provides crucial information for developing effective dengue vaccines.
Researchers at Monash University have discovered how Ebola virus evades the immune system by targeting the STAT3 protein. The virus uses a protein called VP24 to disable STAT3's messenger function, which is critical for regulating host immune and inflammatory responses.
Researchers have identified a novel virulence trait of Streptococcus pneumoniae that increases the severity of S. pneumoniae superinfection following flu. The surface protein PspA, previously known to have several other virulence mechanisms, now functions as an adhesin to dying lung epithelial cells. This finding provides further expla...
Researchers at Texas Biomedical Research Institute are receiving NIH funding to investigate the precise mechanisms of Ebola virus infection, including its ability to hijack immune cells called macrophages. The study aims to understand how the virus spreads in the body and potentially develops targeted treatments.
A new study reveals that a specific antibody molecule, missing fucose, can indicate when dengue virus infection will become deadly. Patients with severe disease have unusually high levels of these antibodies, which bind too strongly to white blood cells, leading to inflammation and platelet destruction.
A team of Colorado State University scientists detected Zika virus RNA in free-ranging African bats, shedding light on the ecology of flaviviruses and potential natural transmission routes. The findings suggest that bats may be incidental hosts of Zika virus infection, rather than amplifying hosts or reservoir hosts.
Researchers have developed an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus, a highly lethal tick-borne disease. The therapy, called DVD-121-801, overcomes infection in mice with just one dose administered after virus exposure.
A new model predicts that rising temperatures in the UK will increase the risk of West Nile virus outbreaks, which are spread by mosquitoes with no vaccine available. The risk is currently low but expected to rise as temperatures increase.
Researchers from University of British Columbia and Strategic Salmon Health Initiative found Piscine orthoreovirus (PRV) originating from Atlantic salmon farms spreading to wild Pacific salmon through open-net farming. The study suggests a link between PRV transmission and increased disease severity in Chinook salmon.
Researchers found that T cells can make mistakes when identifying healthy cells from infected ones, even when binding tightly to antigens. This discovery may lead to new treatments for autoimmune diseases and improve cancer therapies.
Researchers discovered a novel molecular mechanism by which HCV interferes with the host's immune system, leading to chronic infection. The study found that HCV core protein is degraded via SPP and MHC class I proteins, impairing proper immune response and allowing infection to become chronic.
Researchers at the University of Vermont have discovered new biomarkers for predicting clinical and immune responses to dengue virus infection. These findings could aid in the development of more effective vaccines against all four dengue strains, a crucial step in combating this deadly disease.
Researchers have developed a pioneering plant-based technology to study the virus maturation process, revealing large structural rearrangements that enable chemical reactions necessary for infection. The study provides valuable insights into the dynamics of an essential part of a virus infection cycle.
Researchers have demonstrated that HERV activation can impair brain development, leading to altered cortical neuron function and structure. This finding has important clinical implications, particularly in the context of neurodegenerative diseases.
A new study published in Nature Medicine proposes that microbes exist as networks, driving frequent flare-ups in patients with bronchiectasis. The research team analyzed over 400 respiratory samples and found negative interactions between microbes contributing to infection severity.
Researchers found that hygiene measures such as heat, soap, and alcohol treatment can effectively eliminate new coronavirus variants. The variants have similar surface stability to the wild type virus but can be rendered harmless by these methods.
A dengue virus vaccine candidate has produced a protective immune response in infected mice, offering a promising alternative to existing vaccines. The UQ-developed vaccine uses an Australian insect virus and can be administered via a microarray patch for easy, needle-free delivery.
Researchers have improved a method to prevent human parainfluenza virus attachment to cells, leading to 30% to 40% of childhood respiratory illnesses. The new peptide is more effective and persistent in rodent models.
Researchers developed an intranasal influenza vaccine using recombinant hemagglutinin and found it enhanced immune responses in mice. The vaccine showed superior immunoenhancing properties and conferred protection against both same and different virus strains.
Scientists at Scripps Research have discovered how some antibodies can broadly neutralize ebolaviruses by targeting a key site on the virus called the glycan cap. This breakthrough may lead to the development of an antibody-based treatment that can save lives against a range of ebolavirus species.
A UC Riverside virologist has received a $1.9 million award to investigate how the Zika virus beats human defenses, with the goal of developing a vaccine and antiviral drug. The research aims to understand how the virus triggers the degradation of STAT2, a key host factor in activating interferons.
A new study describes broadly neutralizing antibodies that can prevent and potentially treat tick-borne encephalitis. These antibodies, known as VH3-48, have shown promise in preventing the disease and even treating it, as well as other tick-borne viruses.
A new diagnostic test, called the D4-assay, has been developed to detect Ebola virus infection earlier than the current industry standard PCR test. The test is highly sensitive and can detect the virus a full day earlier than PCR, making it a promising tool in addressing ongoing outbreaks.
Researchers at the Walter and Eliza Hall Institute have discovered a critical immune cell type called cDC1 that helps control cancer and infections. The study highlights the importance of DC-SCRIPT, a new regulatory protein, in producing effective dendritic cells.
Researchers developed a safe and cheap technology to disinfect packed eggs with an electron beam. The technology kills bacteria without affecting the quality of meat or eggshell composition. Healthy chickens emerge from disinfected eggs, leading to improved immunity against diseases like Newcastle disease.
A new study by researchers at WashU Medicine found that children hospitalized with RSV are likely to get sicker if they have high levels of defective viral genomes. These defective genomes can trigger a strong antiviral immune response, but timing matters in determining the course of illness.
A study of 2119 adults with confirmed viral acute respiratory infections found that noninfluenza viruses (NIRV) caused illness rates and death similar to influenza. Patients with NIRV infections were generally younger but had underlying conditions, such as compromised immune systems.
A recent study reveals that long-term infection and chronic inflammation lead to a decline in immune function, particularly in older adults. The research found that Dnmt3a-loss of function HSCs exhibit increased self-renewal and reduced differentiation into immune cells, ultimately outcompeting normal HSCs.
A new study published in Nature Communications shows that combining monoclonal antibodies and remdesivir is effective in treating advanced Marburg virus disease. The combination therapy demonstrated an 80% protection rate against the lethal virus, offering promise for treatment of advanced infections.
Scientists have identified unique infection patterns used by four Candida species, which cause 90% of candidiasis cases. The study reveals that human vaginal epithelial cells respond similarly to different species, with their response modulated according to the severity of the infection.
Researchers identified a new hepatitis B virus in donkeys and zebras that causes prolonged infections, potentially leading to better understanding of chronic hepatitis B and development of new therapies.
Researchers found that a combination of an immune receptor blocker and an antiviral agent improves survival in mice infected with lethal influenza. The treatment reduces lung pathology in swine-influenza-infected piglets, providing insights into optimal timing of treatment to prevent acute lung injury.
Researchers at Princeton University have discovered how five cellular proteins contribute to the formation of covalently closed circular DNA (cccDNA) from relaxed circular DNA (rcDNA), a crucial step in HBV's life cycle. This finding provides potential strategies for developing new treatments for chronic HBV infection.
A large-scale chikungunya outbreak in Thailand from 2018-2019 was likely caused by the introduction of a CHIKV strain from South Asia. The study, published in PLOS ONE, highlighted the importance of global health surveillance and preparedness against vector-borne diseases.
Researchers from NIH's National Institute of Allergy and Infectious Diseases have developed a human cerebral organoid model to screen drugs for potential treatment of Creutzfeldt-Jakob Disease, a fatal neurodegenerative brain disease. The model has shown promise in reducing disease indicators by 10-fold without causing tissue death.
Researchers at NYU Langone Health discovered that sphingosine 1 phosphate (S1P) levels in lymph nodes increase as the immune response mounts, leading to inflammation and damage. This finding could lead to better drugs used to fight inflammation, such as medications already approved for inflammatory bowel disease and multiple sclerosis.
A new study from China Agricultural University investigates the role of Hsc70-2 protein in virus-host interaction, identifying key amino acids responsible for systemic infection. The research supports a scenario where viral coat protein adaptations ensure better survival and spread among different plant hosts.
Among Ecuador's Shuar people, market integration is linked to higher levels of disgust sensitivity and lower infection rates. Disgust helps regulate exposure to pathogens and varies across households and communities.
Risk models developed by University of Malaga researchers use artificial intelligence to forecast West Nile virus outbreaks based on environmental variables such as temperature, humidity, and river presence. The study predicts areas at high risk of outbreak in European regions.
Researchers at the NIH used bacteriophages to treat mice infected with multidrug-resistant Klebsiella pneumoniae sequence type 258, showing promising results in reducing bacterial loads. However, phage resistance was also observed in some cases, highlighting the need for further investigation.
A study found that older adults understand the risks of overusing antibiotics, but many still use them incorrectly. Over 91% of respondents are cautious about using antibiotics, yet nearly 56% believe doctors overprescribe them, while 34% think antibiotics can help with viral illnesses like colds and flu.
A new analysis of thousands of Michigan bees reveals that the most diverse bee communities have the lowest levels of three common viral pathogens. This study suggests that promoting diverse bee communities may be a win-win strategy to reduce viral infections in managed honeybee colonies while maintaining native bee biodiversity.
A three-model approach was used to trace the spread of PEDV and analyze control strategies. The models showed varying levels of accuracy in predicting outbreaks, with PoPS being the most accurate overall.
Researchers at Osaka City University demonstrated the mechanism behind FMT, showing how FMT can restore human intestinal flora by replacing damaged microflora with a healthy one. The study reveals the crucial role of bacteriophages and their host bacteria in the pathogenesis of rCDI and its recovery.
Researchers have identified a novel phage called ES17 that can specifically locate and destroy bacteria in the gastrointestinal tract. The phage's ability to bind to mucins and heparan sulfate enables it to target bacteria in high-mucin environments, potentially preventing infections.
A study found that plant species richness reduces viral infections in both wild and cultivated meadow environments. In contrast, the number of virus species increases near agricultural fields due to confusing disease regulation mechanisms.
Researchers at the University of Illinois Chicago have discovered a second site on the filovirus glycoprotein that small drug molecules can bind to prevent infection. This finding holds promise for developing effective treatments for Ebola and Marburg viruses, which cause hemorrhagic fever with mortality rates ranging from 25% to 90%.
Researchers have developed a combination therapy that can potentially heal hepatitis B by shutting down the viral genome in infected liver cells. The treatment targets the HBx protein, which protects the genetic material from being silenced, allowing for sustained shutdown of the virus.
A standard water treatment technique, iron coagulation, efficiently removes and inactivates enveloped viruses by forming precipitates that trap the viral envelopes. This method is more effective than chlorine disinfection, with a reduction of 100,000 times active virus in 2.6 minutes.
A new study published in Nature Microbiology reveals how Zika virus causes brain calcification, a common birth defect associated with prenatal infection. The research team identified the proteins BMP2 and NS3 as central players in the development of calcifications, suggesting novel strategies to prevent this birth defect.
Researchers at University of Missouri developed genetically modified mosquitoes resistant to Zika virus using CRISPR gene-editing technology. These 'suicide mosquitos' cannot transmit the disease and can interrupt the disease cycle, making them a potential solution for controlling the spread of Zika virus.
Researchers have discovered an antibody, 2B7, that physically blocks the Non-Structural Protein 1 (NS1) protein, preventing the dengue virus from attaching to cells and slowing its spread. This breakthrough could lead to new treatments for other flaviviruses like Zika and West Nile.
A study published in PNAS found that RESTV infects pigs and causes severe respiratory disease, shedding the virus from their upper respiratory tract. The researchers also identified RESTV sequences in pigs in China, highlighting the potential for widespread transmission.
The Nobel Prize in Physiology or Medicine was awarded to researchers who discovered the hepatitis C virus (HCV). The discovery was made possible by the perseverance and determination of thousands of scientists worldwide. Their work has paved the way for future research into HCV and potential cures.
A $10 million project led by University of California - Riverside is investigating tiny underground microorganisms for a cure to fatal citrus disease. The research team will test whether soil amendments can suppress parasitic microorganisms and give trees more strength to combat diseases like HLB.
Scientists developed a novel smartphone-based technique to diagnose viral infections using a deep learning algorithm that identifies viruses in metal nanoparticle-labeled samples with 98.97% sensitivity. The system correctly identified clinically relevant concentrations of Zika, hepatitis B and C in patient samples.
Two Monash University scientists found that the enzyme DOT1L plays a critical role in controlling T cell differentiation and function. Genetically eliminating DOT1L led to type 1 T cells dominating, which could lead to new treatments for asthma and allergies.
The USPSTF recommends screening for hepatitis B virus infection in adolescents and adults at increased risk due to its effectiveness in reducing mortality and hepatocellular carcinoma. Antiviral therapy improves intermediate outcomes associated with better health outcomes, strengthening the 2014 recommendation.